Learn how in vitro diagnostic (IVD) devices can comply with IVDR and Indian MDR standards, ensuring regulatory alignment, ...

GlucoModicum Reports Positive Clinical Results with its Needle-Free CGM and Advances Toward Market Launch Comprehensive clinical performance study encompassed 646 participant visits, including both ...

Global Cystatin C Assay Market is valued at approximately USD 350.70 million in 2022 and is anticipated to grow with a healthy growth rate of more than 7.5% during the forecast period 2023-2030. Read ...

Revolutionary Platform Sets New Benchmark for Transparency and Compliance in Diagnostic AI As the May 26th CE-IVDR compliance deadline comes into effect, Diagnostics.ai launches the industry’s ...

A challenge of IVDR is the ability to keep up with research advancements and allow manufacturers to make improvements to kits easily. The pharmacogenomics sector is constantly changing.

Adaptive Biotechnologies Corporation (NASDAQ: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and ...

Qlucore, a leader in software development for precision cancer diagnostics, received a prestigious grant of 2.5 million Euros during 2024. The grant is divided into four installments. The aim of the ...

Invivoscribe's subsidiary, LabPMM, has secured New York State (NYS) approval for the NPM1 MRD Assay to combat acute myeloid ...